cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AA310749 | .a | 6254 to 6743 | 1 to 490 | 490/491 (99 %) | 6 diff (98.8 %id) | ||||
AA330672 | embryo | .a | 3221 to 3603 | 1 to 383 | 383/383 (100 %) | 10 diff (97.4 %id) | |||
AF004291 | .a | 333 to 1911 | 263 to 1841 | tiling clone, | 1579/1842 (85 %) | 5 diff (99.8 %id) | |||
AW950466 | .a | 3222 to 3901 | 1 to 685 | 685/702 (97 %) | 12 diff (98.3 %id) | ||||
AW950468 | .a | 3222 to 3654 | 1 to 432 | 432/432 (100 %) | 7 diff (98.4 %id) | ||||
AW965745 | .a | 6255 to 6753 | 1 to 497 | 497/558 (89 %) | 8 diff (98.6 %id) | ||||
AW972267 | .a | 5008 to 5553 | 546 to 1 | Submitted on the opposite strand | 546/547 (99 %) | 9 diff (98.4 %id) | |||
AW972270 | .a | 4886 to 5553 | 669 to 1 | Submitted on the opposite strand | 669/669 (100 %) | 12 diff (98.3 %id) | |||
BC030600 | testis | .c | 35 to 1934 | 8 to 1907 | exact | tiling clone, available from MGC, AAA | 1900/1907 (99 %) | 7 diff (99.7 %id) | |
BF373095 | prostate_tumor | .a | 5645 to 6033 | 1 to 389 | 389/389 (100 %) | 0 diff (100 %id) | |||
BF375991 | testis_normal | .a | 3653 to 3977 | 326 to 5 | 322/340 (94 %) | 0 diff (100 %id) | |||
BF805797 | colon_ins | .a | 5329 to 5620 | 1 to 291 | 291/292 (99 %) | 11 diff (96.3 %id) | |||
BF902181 | marrow | .a | 4853 to 5360 | 508 to 1 | Submitted on the opposite strand | 508/508 (100 %) | 12 diff (97.7 %id) | ||
BM312527 | Pancreas, Purified pancreatic islet | .a | 5807 to 6267 | 1 to 461 | 461/461 (100 %) | 0 diff (100 %id) | |||
BM353106 | Pancreas, Purified pancreatic islet | .a | 5877 to 6354 | 478 to 1 | 478/478 (100 %) | 0 diff (100 %id) | |||
BQ368213 | placenta_normal | .a | 2313 to 2649 | 1 to 336 | 336/336 (100 %) | 1 diff (99.8 %id) | |||
BX113756 | .a | 1484 to 1896 | 1 to 413 | AAA | 413/413 (100 %) | 2 diff (99.6 %id) | |||
BX116009 | .a | 5094 to 5555 | 1 to 462 | 462/462 (100 %) | 0 diff (100 %id) | ||||
CD630774 | .a | 121 to 839 | 1 to 724 | 724/724 (100 %) | 7 diff (99.1 %id) | ||||
CN369187 | embryonic stem cells, DMSO-treated H9 cellline | .a | 6163 to 6585 | 1 to 423 | 423/423 (100 %) | 2 diff (99.6 %id) | |||
CR748619 | pooled | .a | 5159 to 5554 | 1 to 396 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 396/396 (100 %) | 0 diff (100 %id) | |
BX340753 | .e | 1 to 694 | 1 to 690 | tiling clone, | 690/690 (100 %) | 6 diff (99.2 %id) | |||
BX390656 | .a | 853 to 1771 | 1 to 912 | 912/912 (100 %) | 16 diff (98.3 %id) | ||||
BX485266 | .a | 2771 to 3329 | 1 to 560 | 560/560 (100 %) | 6 diff (99.0 %id) | ||||
BX509410 | .a | 3306 to 3800 | 1 to 495 | 495/495 (100 %) | 0 diff (100 %id) | ||||
DN604416 | .a | 5450 to 5642 | 194 to 1 | 194/196 (98 %) | 1 diff (99.5 %id) | ||||
DA570711 | whole embryo, mainly head | .a | 5579 to 6372 | 2 to 794 | capped | 793/795 (99 %) | 5 diff (99.4 %id) | ||
DB357500 | whole embryo, mainly head | .a | 6661 to 7051 | 391 to 1 | 391/391 (100 %) | 1 diff (99.8 %id) | |||
N30069 | placenta | .a | 6649 to 7047 | 400 to 1 | fully sequenced, | 400/400 (100 %) | 3 diff (99.3 %id) | ||
N40774 | placenta | .a | 6357 to 6679 | 1 to 327 | fully sequenced, | 327/327 (100 %) | 2 diff (99.4 %id) | ||
AA176289 | .a | 5761 to 6347 | 586 to 1 | 586/587 (99 %) | 8 diff (98.7 %id) | ||||
AA176388 | .a | 4964 to 5395 | 1 to 439 | 439/439 (100 %) | 10 diff (97.8 %id) | ||||
AA421578 | .a | 6195 to 6348 | 1 to 153 | 153/168 (91 %) | 3 diff (98.3 %id) | ||||
AA609460 | .a | 5936 to 6357 | 422 to 1 | 422/422 (100 %) | 0 diff (100 %id) | ||||
AA467752 | .a | 6682 to 7051 | 1 to 369 | AAA | Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) | 369/369 (100 %) | 9 diff (97.6 %id) | ||
AA467934 | .a | 6880 to 7051 | 177 to 5 | 173/177 (97 %) | 0 diff (100 %id) | ||||
AA503370 | colon | .a | 6041 to 6355 | 314 to 1 | 314/314 (100 %) | 2 diff (99.4 %id) | |||
AA563667 | colon | .a | 5286 to 5555 | 270 to 1 | 270/270 (100 %) | 0 diff (100 %id) | |||
AA494200 | thyroid | .a | 6567 to 6999 | 39 to 472 | 434/472 (91 %) | 6 diff (98.8 %id) | |||
AA760925 | pooled germ cell tumors | .a | 6622 to 7045 | 434 to 12 | AAA | Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) | 423/423 (100 %) | 1 diff (99.8 %id) | |
AA935140 | pooled | .a | 6711 to 7046 | 338 to 3 | 336/338 (99 %) | 0 diff (100 %id) | |||
AA991937 | pooled germ cell tumors | .a | 5114 to 5554 | 441 to 1 | 441/441 (100 %) | 0 diff (100 %id) | |||
AA991979 | pooled germ cell tumors | .a | 5280 to 5554 | 275 to 1 | 275/275 (100 %) | 1 diff (99.7 %id) | |||
AI075907 | .a | 3300 to 3784 | 488 to 4 | 485/488 (99 %) | 0 diff (100 %id) | ||||
AI028611 | .a | 1517 to 1898 | 385 to 4 | 382/385 (99 %) | 0 diff (100 %id) | ||||
AI191939 | .a | 5125 to 5556 | 432 to 1 | 432/432 (100 %) | 0 diff (100 %id) | ||||
AI337208 | pooled germ cell tumors | .a | 5104 to 5554 | 451 to 1 | 451/451 (100 %) | 1 diff (99.8 %id) | |||
AI341253 | pooled germ cell tumors | .a | 5825 to 6357 | 534 to 1 | 534/534 (100 %) | 14 diff (97.4 %id) | |||
AI419976 | pooled | .a | 6564 to 7050 | 492 to 6 | 487/492 (98 %) | 0 diff (100 %id) | |||
AI476272 | Kidney | .a | 5857 to 6356 | 499 to 1 | 499/502 (99 %) | 1 diff (99.9 %id) | |||
AI476409 | pooled | .a | 1518 to 1898 | 384 to 4 | 381/384 (99 %) | 0 diff (100 %id) | |||
AI631533 | pooled germ cell tumors | .a | 5886 to 6346 | 469 to 9 | 461/469 (98 %) | 0 diff (100 %id) | |||
AI708781 | aorta | .a | 6604 to 7051 | 451 to 4 | 448/451 (99 %) | 0 diff (100 %id) | |||
AI693165 | carcinoid, lung | .a | 5287 to 5530 | 1 to 244 | Submitted on the opposite strand | 244/244 (100 %) | 0 diff (100 %id) | ||
AI797388 | pooled | .a | 6125 to 6354 | 230 to 1 | 230/230 (100 %) | 0 diff (100 %id) | |||
AI807046 | pooled | .a | 5198 to 5558 | 361 to 1 | 361/361 (100 %) | 6 diff (98.4 %id) | |||
AI972860 | Prostate | .a | 5125 to 5548 | 424 to 1 | 424/424 (100 %) | 1 diff (99.8 %id) | |||
AW002379 | pooled germ cell tumors | .a | 5186 to 5554 | 369 to 1 | 369/369 (100 %) | 1 diff (99.8 %id) | |||
AW081764 | pooled | .a | 6670 to 7046 | 383 to 3 | 381/426 (89 %) | 0 diff (100 %id) | |||
AW148861 | brain, tumor, 5 pooled (see description) | .a | 6616 to 7047 | 445 to 14 | AAA | Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) | 432/432 (100 %) | 3 diff (99.4 %id) | |
AW135235 | .a | 5274 to 5571 | 1 to 297 | Submitted on the opposite strand | 297/305 (97 %) | 4 diff (98.7 %id) | |||
AW305372 | brain, three pooled meningiomas | .a | 5137 to 5572 | 436 to 1 | 436/436 (100 %) | 1 diff (99.8 %id) | |||
AW613132 | colon, moderately-differentiated adenocarcinoma | .a | 6705 to 7046 | 359 to 18 | 342/359 (95 %) | 0 diff (100 %id) | |||
AW732909 | choriocarcinoma, placenta | .a | 5065 to 5554 | 520 to 31 | AAA | Submitted on the opposite strand | 490/490 (100 %) | 0 diff (100 %id) | |
AW628978 | pooled | .a | 6692 to 7046 | 358 to 3 | 356/358 (99 %) | 0 diff (100 %id) | |||
BE018500 | cervix | .a | 5118 to 5561 | 445 to 1 | Submitted on the opposite strand | 445/445 (100 %) | 1 diff (99.8 %id) | ||
AW452427 | .a | 6831 to 7045 | 232 to 18 | AAA | Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) | 215/215 (100 %) | 0 diff (100 %id) | ||
BF509290 | .a | 6351 to 6830 | 480 to 1 | 480/483 (99 %) | 3 diff (99.4 %id) | ||||
BE279239 | choriocarcinoma, placenta | .a | 6319 to 6850 | 1 to 532 | 532/532 (100 %) | 7 diff (98.7 %id) | |||
BE549861 | pooled germ cell tumors | .a | 5854 to 6354 | 501 to 1 | 501/501 (100 %) | 0 diff (100 %id) | |||
BE540373 | cervix | .a | 6397 to 7041 | 1 to 640 | 640/640 (100 %) | 8 diff (98.8 %id) | |||
BE541244 | cervix | .a | 5744 to 6455 | 1 to 717 | 717/767 (93 %) | 31 diff (96.0 %id) | |||
BF059563 | pooled germ cell tumors | .a | 5826 to 6354 | 529 to 1 | 529/529 (100 %) | 0 diff (100 %id) | |||
BE407934 | choriocarcinoma, placenta | .a | 4813 to 5420 | 662 to 56 | Submitted on the opposite strand | 607/797 (76 %) | 0 diff (100 %id) | ||
BF224098 | carcinoid, lung | .a | 5281 to 5529 | 1 to 249 | Submitted on the opposite strand | 249/249 (100 %) | 0 diff (100 %id) | ||
BE731749 | choriocarcinoma, placenta | .d | 1 to 742 | 1 to 734 | C21V D23T R24A A25L T26Q ... | tiling clone, | 734/776 (94 %) | 11 diff (98.6 %id) | |
BE899143 | adenocarcinoma cell line, ovary | .a | 6717 to 7043 | 1 to 327 | 327/327 (100 %) | 0 diff (100 %id) | |||
BG720552 | testis | .a | 3981 to 4440 | 1 to 456 | tiling clone, | 456/482 (94 %) | 14 diff (97.1 %id) | ||
BC042406. matches multiple genes | testis | .c | 32 to 1934 | 1 to 1903 | available from MGC, AAA | also hits gene floywubo | 1903/1903 (100 %) | 5 diff (99.8 %id) | |
BC042395. matches multiple genes | testis | .c | 32 to 1934 | 1 to 1903 | exact | tiling clone, available from MGC, AAA | Submitted on the opposite strand, also hits gene ARSJ | 1903/1903 (100 %) | 5 diff (99.8 %id) |
BC027988 | Placenta, choriocarcinoma | .a | 4508 to 6354 | 11 to 1857 | tiling clone, available from MGC, AAA | Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) | 1847/1847 (100 %) | 2 diff (99.9 %id) | |
BI087700 | cervix | .a | 4509 to 5223 | 1 to 713 | available from MGC, | 713/714 (99 %) | 7 diff (99.1 %id) | ||
BI094028 | cervix | .a | 1984 to 2743 | 1 to 764 | tiling clone, | 764/775 (98 %) | 26 diff (96.7 %id) | ||
BI093487 | cervix | .a | 5651 to 6423 | 1 to 776 | 776/776 (100 %) | 8 diff (99.0 %id) | |||
BI093583 | cervix | .a | 5651 to 6312 | 1 to 664 | 664/664 (100 %) | 2 diff (99.7 %id) | |||
BI712988 | Pancreas, Purified pancreatic islet | .a | 5807 to 6082 | 1 to 276 | fully sequenced, | 276/276 (100 %) | 0 diff (100 %id) | ||
BI791578 | Pancreas, Purified pancreatic islet | .a | 6052 to 6354 | 303 to 1 | fully sequenced, | 303/303 (100 %) | 0 diff (100 %id) | ||
BI334648 | cervical carcinoma cell line, cervix | .a | 6328 to 7045 | 1 to 716 | AAA | Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) | 716/716 (100 %) | 3 diff (99.6 %id) | |
BM012149 | brain, neuroblastoma, cell line | .a | 4587 to 5420 | 902 to 76 | Submitted on the opposite strand | 827/902 (91 %) | 0 diff (100 %id) | ||
CK822092 | Pancreas, Purified pancreatic islet | .a | 5905 to 6354 | 1 to 450 | AAA | Submitted on the opposite strand | 450/450 (100 %) | 0 diff (100 %id) | |
CK822093 | Pancreas, Purified pancreatic islet | .a | 5789 to 6354 | 577 to 12 | AAA | Submitted on the opposite strand | 566/583 (97 %) | 0 diff (100 %id) | |
BQ278164 | ovary, teratocarcinoma, cell line | .a | 1280 to 2079 | 1 to 806 | 806/1073 (75 %) | 6 diff (99.5 %id) | |||
BQ278173 | ovary, teratocarcinoma, cell line | .a | 2317 to 3252 | 1 to 949 | 949/1058 (89 %) | 24 diff (97.8 %id) | |||
BU846219 | ovary, teratocarcinoma, cell line | .a | 2316 to 3267 | 37 to 994 | 958/994 (96 %) | 6 diff (99.4 %id) | |||
BU553662 | ovary, teratocarcinoma, cell line | .a | 1280 to 1896 | 1 to 633 | 633/842 (75 %) | 30 diff (96.5 %id) | |||
BU849660 | ovary, teratocarcinoma, cell line | .a | 2317 to 3131 | 1 to 826 | 826/857 (96 %) | 12 diff (98.6 %id) | |||
BU859477 | ovary, teratocarcinoma, cell line | .a | 2318 to 3111 | 1 to 808 | 808/945 (85 %) | 42 diff (95.6 %id) | |||
CX783306 | human embryonic stem cells | .a | 6085 to 6924 | 1 to 840 | tiling clone, | 840/840 (100 %) | 0 diff (100 %id) | ||
CX785726 | human embryonic stem cells | .a | 5160 to 5927 | 1 to 768 | 768/768 (100 %) | 0 diff (100 %id) | |||
CX788721 | human embryonic stem cells | .a | 5471 to 6301 | 1 to 831 | 831/831 (100 %) | 0 diff (100 %id) | |||
CV802455 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 5099 to 5825 | 1 to 719 | 719/843 (85 %) | 14 diff (98.4 %id) | |||
CX752796 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 5718 to 6423 | 1 to 697 | Submitted on the opposite strand | 697/755 (92 %) | 10 diff (98.7 %id) | ||
CX759937 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 5062 to 5833 | 1 to 772 | Submitted on the opposite strand | 772/807 (95 %) | 18 diff (97.8 %id) | ||
CX760864 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 5726 to 6475 | 1 to 738 | Submitted on the opposite strand | 738/832 (88 %) | 18 diff (97.9 %id) | ||
DR158283 | human embryonic stem cells differentiated toan early endodermal cell type | .a | 4400 to 4981 | 7 to 588 | 582/588 (98 %) | 6 diff (99.0 %id) | |||
CX163389 | human embryonic stem cells differentiated toan early endodermal cell type | .a | 5531 to 6321 | 1 to 791 | 791/791 (100 %) | 0 diff (100 %id) | |||
TI_59381350 | .a | 4587 to 5420 | 1001 to 175 | Submitted on the opposite strand | 827/901 (91 %) | 0 diff (100 %id) | |||
NM_001489.3 | .c | 48 to 1934 | 1 to 1887 | exact | RefSeq, AAA | 1887/1887 (100 %) | 0 diff (100 %id) | ||
NM_033334.2 | .a | 1 to 1902 | 1 to 1902 | exact | RefSeq, AAA | 1902/1902 (100 %) | 0 diff (100 %id) | ||
AU124060 | .a | 3601 to 4237 | 2 to 638 | tiling clone, capped | 637/637 (100 %) | 5 diff (99.3 %id) | |||
DA734640 | .a | 4401 to 4926 | 2 to 527 | tiling clone, capped | 526/526 (100 %) | 3 diff (99.5 %id) | |||
DB366764 | .a | 6516 to 7052 | 532 to 1 | tiling clone, | 532/537 (99 %) | 7 diff (98.7 %id) | |||
BM787010 | Ascites, stomach | .c | 1 to 248 | 7 to 254 | tiling clone, | 248/254 (97 %) | 6 diff (97.7 %id) | ||
S83309 | .b | 1 to 1890 | 9 to 1898 | exact | tiling clone, AAA | 1890/1898 (99 %) | 6 diff (99.7 %id) | ||
TI_149312006 | .a | 2743 to 3516 | 855 to 88 | AAA | 768/946 (81 %) | 5 diff (99.5 %id) | |||
DB187773 | liver, tumor tissue | .a | 4892 to 5463 | 2 to 573 | capped | 572/572 (100 %) | 0 diff (100 %id) | ||
U64876 | testis | .a | 104 to 1766 | 125 to 1788 | N90K | 1664/1791 (92 %) | 12 diff (99.4 %id) | ||
U80802 | testis | .a | 22 to 1899 | 1 to 1878 | exact | AAA | 1878/1878 (100 %) | 0 diff (100 %id) | |
BQ013360 | placenta | .a | 6597 to 7045 | 467 to 19 | AAA | Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) | 449/449 (100 %) | 0 diff (100 %id) | |
BQ013408 | placenta | .a | 6637 to 7045 | 427 to 19 | AAA | Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) | 409/409 (100 %) | 0 diff (100 %id) | |
BM977734 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .a | 2821 to 3516 | 714 to 19 | AAA | 696/696 (100 %) | 1 diff (99.9 %id) | ||
BM728274 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 5534 to 5955 | 1 to 422 | 422/422 (100 %) | 0 diff (100 %id) | |||
BQ775067 | Bone, Human Chondrosarcoma Cell Line | .a | 1303 to 1752 | 465 to 16 | AAA | 450/450 (100 %) | 1 diff (99.8 %id) | ||
BU622921 | cell lines, Chondrosarcoma | .a | 6377 to 7045 | 687 to 19 | AAA | Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) | 669/669 (100 %) | 0 diff (100 %id) | |
X99975 | testis | .a | 12 to 4199 | 56 to 4242 | A129T | tiling clone, | 4187/4243 (98 %) | 13 diff (99.7 %id) | |
AW237089 | pooled germ cell tumors | .a | 5099 to 5825 | 1 to 719 | This clone was ignored | 719/843 (85 %) | 14 diff (98.4 %id) | ||
CX752796 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 5718 to 6423 | 1 to 697 | Submitted on the opposite strand | 697/755 (92 %) | 10 diff (98.7 %id) | ||
CX752796 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 5718 to 6423 | 1 to 697 | Submitted on the opposite strand | 697/755 (92 %) | 10 diff (98.7 %id) | ||
CX759937 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 5062 to 5833 | 1 to 772 | Submitted on the opposite strand | 772/807 (95 %) | 18 diff (97.8 %id) | ||
CX759937 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 5062 to 5833 | 1 to 772 | Submitted on the opposite strand | 772/807 (95 %) | 18 diff (97.8 %id) | ||
CX760864 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 5726 to 6475 | 1 to 738 | Submitted on the opposite strand | 738/832 (88 %) | 18 diff (97.9 %id) | ||
CX760864 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 5726 to 6475 | 1 to 738 | Submitted on the opposite strand | 738/832 (88 %) | 18 diff (97.9 %id) | ||
DR158283 | human embryonic stem cells differentiated toan early endodermal cell type | .a | 4400 to 4981 | 7 to 588 | 582/588 (98 %) | 6 diff (99.0 %id) | |||
CX163389 | human embryonic stem cells differentiated toan early endodermal cell type | .a | 5531 to 6321 | 1 to 791 | 791/791 (100 %) | 0 diff (100 %id) | |||
TI_59381350 | .a | 4587 to 5420 | 1001 to 175 | Submitted on the opposite strand | 827/901 (91 %) | 0 diff (100 %id) | |||
NM_001489.3 | .c | 48 to 1934 | 1 to 1887 | exact | RefSeq, AAA | 1887/1887 (100 %) | 0 diff (100 %id) | ||
NM_033334.2 | .a | 1 to 1902 | 1 to 1902 | exact | RefSeq, AAA | 1902/1902 (100 %) | 0 diff (100 %id) | ||
AU124060 | .a | 3601 to 4237 | 2 to 638 | tiling clone, capped | 637/637 (100 %) | 5 diff (99.3 %id) | |||
DA734640 | .a | 4401 to 4926 | 2 to 527 | tiling clone, capped | 526/526 (100 %) | 3 diff (99.5 %id) | |||
DB366764 | .a | 6516 to 7052 | 532 to 1 | tiling clone, | 532/537 (99 %) | 7 diff (98.7 %id) | |||
BM787010 | Ascites, stomach | .c | 1 to 248 | 7 to 254 | tiling clone, | 248/254 (97 %) | 6 diff (97.7 %id) | ||
BM787010 | Ascites, stomach | .c | 1 to 248 | 7 to 254 | tiling clone, | 248/254 (97 %) | 6 diff (97.7 %id) | ||
S83309 | .b | 1 to 1890 | 9 to 1898 | exact | tiling clone, AAA | 1890/1898 (99 %) | 6 diff (99.7 %id) | ||
TI_149312006 | .a | 2743 to 3516 | 855 to 88 | AAA | 768/946 (81 %) | 5 diff (99.5 %id) | |||
DB187773 | liver, tumor tissue | .a | 4892 to 5463 | 2 to 573 | capped | 572/572 (100 %) | 0 diff (100 %id) | ||
U64876 | testis | .a | 104 to 1766 | 125 to 1788 | N90K | 1664/1791 (92 %) | 12 diff (99.4 %id) | ||
U80802 | testis | .a | 22 to 1899 | 1 to 1878 | exact | AAA | 1878/1878 (100 %) | 0 diff (100 %id) | |
BQ013360 | placenta | .a | 6597 to 7045 | 467 to 19 | AAA | Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) | 449/449 (100 %) | 0 diff (100 %id) | |
BQ013408 | placenta | .a | 6637 to 7045 | 427 to 19 | AAA | Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) | 409/409 (100 %) | 0 diff (100 %id) | |
BM977734 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .a | 2821 to 3516 | 714 to 19 | AAA | 696/696 (100 %) | 1 diff (99.9 %id) | ||
BM977734 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .a | 2821 to 3516 | 714 to 19 | AAA | 696/696 (100 %) | 1 diff (99.9 %id) | ||
BM728274 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 5534 to 5955 | 1 to 422 | 422/422 (100 %) | 0 diff (100 %id) | |||
BM728274 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 5534 to 5955 | 1 to 422 | 422/422 (100 %) | 0 diff (100 %id) | |||
BQ775067 | Bone, Human Chondrosarcoma Cell Line | .a | 1303 to 1752 | 465 to 16 | AAA | 450/450 (100 %) | 1 diff (99.8 %id) | ||
BQ775067 | Bone, Human Chondrosarcoma Cell Line | .a | 1303 to 1752 | 465 to 16 | AAA | 450/450 (100 %) | 1 diff (99.8 %id) | ||
BU622921 | cell lines, Chondrosarcoma | .a | 6377 to 7045 | 687 to 19 | AAA | Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) | 669/669 (100 %) | 0 diff (100 %id) | |
BU622921 | cell lines, Chondrosarcoma | .a | 6377 to 7045 | 687 to 19 | AAA | Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) | 669/669 (100 %) | 0 diff (100 %id) | |
X99975 | testis | .a | 12 to 4199 | 56 to 4242 | A129T | tiling clone, | 4187/4243 (98 %) | 13 diff (99.7 %id) |
? | Gene Summary | Gene on genome | mRNA:.a, .b, .c, .d, .e | Alternative mRNAs features, proteins, introns, exons, sequences | Expression Tissue | Function, regulation, related genes CI |